Condition
Stroke Recurrence
Total Trials
6
Recruiting
2
Active
2
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 27/100
Termination Rate
0.0%
0 terminated out of 6 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
17%
1 trials in Phase 3/4
Results Transparency
50%
1 of 2 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
5Total
Not Applicable (4)
P 3 (1)
Trial Status
Recruiting2
Completed2
Not Yet Recruiting1
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT07500116Not ApplicableRecruiting
NORA-HOME: An Ambulatory Multimodal Monitoring Model In Patients With Minor Stroke And Transient Ischemic Attacks
NCT07120334Not ApplicableRecruitingPrimary
Mobile Health Dietary Intervention for Stroke Survivors With Prediabetes or Type 2 Diabetes
NCT07174414Phase 3Not Yet RecruitingPrimary
Cilostazol for Prevention of Recurrent Stroke Trial
NCT05486351Unknown
Keeping Oral o Parental AnticoaguLation in the Acute Phase of Cardioembolic Ischemic Stroke
NCT04776226Not ApplicableCompletedPrimary
Post-stroke Depression Treatment Effect on Stroke Recurrence
NCT01027273Not ApplicableCompletedPrimary
Prevent Return of Stroke Study
Showing all 6 trials